Serzone and Ear barotrauma - a phase IV clinical study of FDA data

Summary:

Ear barotrauma is reported as a side effect among people who take Serzone (nefazodone hydrochloride), especially for people who are male, 60+ old, also take Elavil, and have Arrhythmias.

The phase IV clinical study analyzes which people have Ear barotrauma when taking Serzone. It is created by eHealthMe based on reports of 7,594 people who have side effects when taking Serzone from the FDA, and is updated regularly.

What is Serzone?

Serzone has active ingredients of nefazodone hydrochloride. It is often used in depression. eHealthMe is studying from 7,695 Serzone users. Check the latest studies of Serzone.

What is Ear barotrauma?

Ear barotrauma (discomfort and possible damage in the ear due to pressure differences between the inside and outside of the eardrum) is found to be associated with 300 drugs and 625 conditions by eHealthMe. Check the latest studies of Ear barotrauma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

7,594 people reported to have side effects when taking Serzone.
Among them, 16 people (0.21%) have Ear barotrauma.

Among these 16 people:

What is the gender of people who have Ear barotrauma when taking Serzone? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Ear barotrauma when taking Serzone? *

What are other drugs people take besides Serzone? *

What are other side effects people have besides Ear barotrauma? *

Joint Pain: 16 people, 100.00%
Back Pain: 14 people, 87.50%
Fall: 14 people, 87.50%
Haematochezia (passage of stools containing blood): 13 people, 81.25%
Enlarged Heart: 13 people, 81.25%
Nasal Septum Deviation (deviated nasal septum): 13 people, 81.25%
Mouth Ulcers: 13 people, 81.25%
Marrow Hyperplasia (increased bone marrow): 13 people, 81.25%
Insomnia (sleeplessness): 13 people, 81.25%
Hydrocele: 13 people, 81.25%

What are the existing conditions these people have? *

Stable Angina (a constant chest pain): 13 people, 81.25%
Multiple Myeloma (cancer of the plasma cells): 13 people, 81.25%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 13 people, 81.25%
Arrhythmias (irregular heartbeat): 13 people, 81.25%
Pain: 1 person, 6.25%
Osteoporosis (bones weak and more likely to break): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Serzone and have Ear barotrauma?

- Check whether Ear barotrauma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Serzone:

Serzone (7,695 reports)

Ear barotrauma treatments and more:

Ear barotrauma (1,478 reports)

Browse all side effects of Serzone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ear barotrauma:

Ear barotrauma (300 drugs)

Browse all the conditions that are associated with Ear barotrauma:

Ear barotrauma (625 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nefazodone hydrochloride (the active ingredients of Serzone) and Serzone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.